LONDON, Nov. 16, 2016 /PRNewswire/ — Single-use Bioprocessing Systems Market: Trends and Opportunities
Bioprocessing is a significant part of biopharmaceutical development and production processes and single-use bioprocessing systems, which are meant for one-time use, have recently found their unique position in the biopharmaceutical and biotherapeutics industry. Biomanufacturing facilities which once housed only stainless steel equipment are paving the way for a hybrid setup which also incorporates single-use technologies. New facilities manufacturing biologics, especially CRO’s/CMO’s and small biotechnology startups are increasingly opting for fully single-use plants. These systems have made the production of clinical trial drugs as well as commercially manufactured drugs cost-effective and flexible. The market for single-use bioprocessing systems is expected to grow at a double-digit figure during the forecast period from 2016 to 2024 and shall be driven by factors such as lowered labor efforts, lowered capital cost, and riddance of time, money, and efforts spent on sterilization procedures.
Single-use Bioprocessing Systems Market: Scope and Methodology
This report on the global single-use bioprocessing systems market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market related factors such as technological developments, product innovation, expansion of infrastructural facilities by major and small pharmaceuticals, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the global single-use bioprocessing systems market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, drug development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.
Single-use Bioprocessing Systems Market: Segmentation
Based on product type, the global single-use bioprocessing systems market has been segmented into bioreactors and fermenters, mixers, bags, filtration devices, tubing, sampling systems, connectors & clamps, and sensors & probes. Bags and bioreactors are the most prominently selling products in the single-use bioprocessing systems market.
Major end-users of single-use bioprocessing systems include pharmaceutical organizations, biotechnology organizations, CRO’s & CMO’s, and academic and research institutes. In terms of applications, the market has been segmented into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. The others segment includes recombinant proteins, enzymes, growth factors etc. The flexibility of single-use systems coupled with the decreased concern related to chances of cross contamination, make single-use bioprocessing systems a prime purchase option for manufacturers involved in monoclonal antibody production.
Geographically, the global single-use bioprocessing systems market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further segmented by major countries. A global overview has been provided, and the North America region has been analyzed in depth at country as well as product, application, and end-user segment level. The countries in North America section include the U.S. and Canada. The regions of Europe, Asia Pacific, Latin America, and Middle East & Africa have been briefly profiled at country level. The countries include the U.K., Germany, France, Italy, China, Japan, Australia & New Zealand, Brazil, Mexico, the UAE, and South Africa.
Single-use Bioprocessing Systems Market: Competitive Landscape
The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the single-use bioprocessing systems market. The report also profiles major players in the single-use bioprocessing systems market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Thermo Fisher Scientific, Merck KGaA (Merck Millipore), Danaher Corporation (Pall Corporation), Sartorius AG, Eppendorf AG, GE Healthcare, PBS Biotech, Inc., Meissner Filtration Products, Finesse Solutions, Sentinel Process Solutions, and Saint-Gobain.
The global single-use bioprocessing systems market has been segmented as follows:
Global Single-use Bioprocessing Systems Market, by Product
Bioreactors & FermentersMixersBagsBioprocess ContainersFiltration DevicesTubingSampling SystemsConnectors & ClampsProbes & Sensors
Global Single-use Bioprocessing Systems Market, by End-user
PharmaceuticalBiotechnologyCRO & CMOAcademic & Research Institutes
Global Single-use Bioprocessing Systems Market, by Application
Monoclonal Antibody ProductionVaccine ProductionPlant Cell CultivationPatient Specific Cell TherapiesOthers (production of enzymes, growth factors etc.)
Global Single-use Bioprocessing Systems Market, by Geography
North AmericaU.S.CanadaAsia PacificChinaJapanAustralia & New ZealandRest of APACEuropeU.K.GermanyFranceItalyRest of EuropeLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaUAESouth AfricaRest of Middle East & Africa
Download the full report: https://www.reportbuyer.com/product/4344779/
Reader insists that the question must be asked
Dear Sirs,
In regard to the mysterious “agro Centre” which has appeared somewhere in the Arabian desert seemingly built and constructed by the New Zealand taxpayer you, the Taxpayers Union, and other questioners have all been asking the wrong question.
The question that you should be asking is this: Is this agri hub the pivot of a counter trade deal between New Zealand and the Saudis?If it is the central component of a counter trade deal then the New Zealand government deserves credit for its imagination in implanting itself into a valuable trade opportunity.
If it is not, and as no direct payment from the Saudi royalty involved appears to be expected, then, you and Mr Williams of the Taxpayers, are correct in assuming that it is all a magnificent bungle.
One contributing reason is that in the Middle East now the demand for live sheep is lessening and the reason is the problem throughout the region in keeping them alive with fresh water.
The reason I am inclined to think, and indeed, hope, that this is a counter trade, perhaps still to be realised at the Saudi end, is that it makes such sense. We could well be looking, for example, at a third country involvement somewhere in say South America or Africa.
In such an instance it would make sense for the Saudi acquirers to send oil to a third party in one of these countries which in turn would send a commodity such as fertiliser to New Zealand in conclusion of the payment cycle.
Such a contingency should now be investigated. Sufficient time has elapsed for such a counter deal to have been rotated. It’s existence or not should now be determined.
Yours trulyHenry KoenigSingapore
| WOOD DALE, Illinois, November 17, 2016 | – AAR (NYSE: AIR), a global leader in the aviation aftermarket, has entered into a long-term contract with Air New Zealand to provide nose-to-tail, cost-per-flight-hour rotable inventory support covering 740 parts and 15 of the airline’s B777 aircraft. Under reciprocal terms of the agreement, Air New Zealand will become AAR’s exclusive component repair provider for selected parts in the Asia-Pacific region and preferred supplier for selected parts worldwide.
This significant contract establishes a component inventory and repair partnership for AAR in the growing Asia-Pacific region with an AAA-rated carrier. It also marks AAR’s first PBH agreement solely focused on the B777 aircraft, the flagship carrier and international workhorse connecting New Zealand to the rest of the world.
“This partnership complements AAR’s in-house component repair facilities in the U.S. and Europe and extends our reach in the fast-growing Australasia region,” said Deepak Sharma, President, AAR International Supply Chain. “We’re proud to team up with an industry-leading long-distance carrier like Air New Zealand to help them create efficiencies with an integrated supply chain solution for their B777 fleet. This is the beginning of a win-winpartnership that we hope will extend to other projects in the region and beyond.”
Air New Zealand Chief Operations Officer Bruce Parton says the deal follows extensive market evaluation and is significant for the airline’s Components business. “We are looking forward to working with a fast-growing partner in AAR that will help to drive a high volume of work and further the commercial success of Air New Zealand’s components business.”
Palace of the Alhambra, Spain
By: Charles Nathaniel Worsley (1862-1923)
From the collection of Sir Heaton Rhodes
Oil on canvas - 118cm x 162cm
Valued $12,000 - $18,000
Offers invited over $9,000
Contact: Henry Newrick – (+64 ) 27 471 2242
Mount Egmont with Lake
By: John Philemon Backhouse (1845-1908)
Oil on Sea Shell - 13cm x 14cm
Valued $2,000-$3,000
Offers invited over $1,500
Contact: Henry Newrick – (+64 ) 27 471 2242